Frederick C Eilber

Summary

Affiliation: University of California
Country: USA

Publications

  1. pmc High-grade extremity soft tissue sarcomas: factors predictive of local recurrence and its effect on morbidity and mortality
    Fritz C Eilber
    Division of Surgical Oncology, 54 140 CHS, UCLA Medical Center, 10833 Le Conte Avenue, Los Angeles, CA 90095 1782, USA
    Ann Surg 237:218-26. 2003
  2. ncbi request reprint Targeted therapies for soft-tissue sarcomas
    William D Tap
    UCLA Sarcoma Program, Division of Hematology Oncology, Los Angeles, CA 90095 7059, USA
    Expert Rev Anticancer Ther 7:725-33. 2007
  3. ncbi request reprint Diagnosis and management of synovial sarcoma
    Fritz C Eilber
    Division of Surgical Oncology, University of California Los Angeles, Los Angeles, California 90095 1782, USA
    J Surg Oncol 97:314-20. 2008
  4. ncbi request reprint Gender dimorphism and age of onset in malignant peripheral nerve sheath tumor preclinical models and human patients
    Elizabeth Shurell
    Department of Surgery, University of California Los Angeles, Division of Surgical Oncology, 10833 Le Conte Ave, Room 54 140 CHS, 90095 1782 Los Angeles, California
    BMC Cancer 14:827. 2014
  5. ncbi request reprint Advances in chemotherapy for patients with extremity soft tissue sarcoma
    Fritz C Eilber
    University of California, Los Angeles, UCLA Medical Center, 90095 1782, USA
    Orthop Clin North Am 37:15-22. 2006
  6. ncbi request reprint Sarcoma nomogram: validation and a model to evaluate impact of therapy
    Frederick C Eilber
    Division of Surgical Oncology, University of California, Los Angeles, CA 90095 1782, USA
    J Am Coll Surg 205:S90-5. 2007
  7. pmc Chemotherapy is associated with improved survival in adult patients with primary extremity synovial sarcoma
    Fritz C Eilber
    Division of Surgical Oncology, University of California Los Angeles, Los Angeles, CA, USA
    Ann Surg 246:105-13. 2007
  8. pmc FDG-PET/CT imaging predicts histopathologic treatment responses after the initial cycle of neoadjuvant chemotherapy in high-grade soft-tissue sarcomas
    Matthias R Benz
    Ahmanson Biological Imaging Division, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, California 90095 1782, USA
    Clin Cancer Res 15:2856-63. 2009
  9. pmc The Friedman-Eilber resection arthroplasty of the pelvis
    Adam J Schwartz
    Department of Orthopaedic Surgery, University of California, Los Angeles Medical Center, Santa Monica, 1250 16th Street, 7th Floor, Los Angeles, CA, 90404, USA
    Clin Orthop Relat Res 467:2825-30. 2009
  10. ncbi request reprint Evaluation of neoadjuvant therapy and histopathologic response in primary, high-grade retroperitoneal sarcomas using the sarcoma nomogram
    Timothy R Donahue
    Department of Surgery, Division of Surgical Oncology, University of California at Los Angeles, Los Angeles, California 90095 1782, USA
    Cancer 116:3883-91. 2010

Collaborators

Detail Information

Publications14

  1. pmc High-grade extremity soft tissue sarcomas: factors predictive of local recurrence and its effect on morbidity and mortality
    Fritz C Eilber
    Division of Surgical Oncology, 54 140 CHS, UCLA Medical Center, 10833 Le Conte Avenue, Los Angeles, CA 90095 1782, USA
    Ann Surg 237:218-26. 2003
    ..To identify patient characteristics associated with the development of local recurrence and the effect of local recurrence on subsequent morbidity and mortality in patients with intermediate- to high-grade extremity soft tissue sarcomas...
  2. ncbi request reprint Targeted therapies for soft-tissue sarcomas
    William D Tap
    UCLA Sarcoma Program, Division of Hematology Oncology, Los Angeles, CA 90095 7059, USA
    Expert Rev Anticancer Ther 7:725-33. 2007
    ..This review will outline current areas of therapeutic interest in soft-tissue sarcomas with regard to agents that have reached clinical testing...
  3. ncbi request reprint Diagnosis and management of synovial sarcoma
    Fritz C Eilber
    Division of Surgical Oncology, University of California Los Angeles, Los Angeles, California 90095 1782, USA
    J Surg Oncol 97:314-20. 2008
    ..Although ifosfamide based chemotherapy has been associated with an improved survival in patients with synovial sarcoma, the search for less toxic and more targeted systemic therapies is ongoing...
  4. ncbi request reprint Gender dimorphism and age of onset in malignant peripheral nerve sheath tumor preclinical models and human patients
    Elizabeth Shurell
    Department of Surgery, University of California Los Angeles, Division of Surgical Oncology, 10833 Le Conte Ave, Room 54 140 CHS, 90095 1782 Los Angeles, California
    BMC Cancer 14:827. 2014
    ..Gender-based differences in disease onset in murine models of malignant peripheral nerve sheath tumor (MPNST) and in patients with Neurofibromatosis type-1-(NF-1)-associated or spontaneous MPNST has not been well studied...
  5. ncbi request reprint Advances in chemotherapy for patients with extremity soft tissue sarcoma
    Fritz C Eilber
    University of California, Los Angeles, UCLA Medical Center, 90095 1782, USA
    Orthop Clin North Am 37:15-22. 2006
    ..Until a less toxic targeted systemic therapy is developed, treatment with ifosfamide should be strongly considered in patients who have high-risk primary extremity soft tissue sarcomas...
  6. ncbi request reprint Sarcoma nomogram: validation and a model to evaluate impact of therapy
    Frederick C Eilber
    Division of Surgical Oncology, University of California, Los Angeles, CA 90095 1782, USA
    J Am Coll Surg 205:S90-5. 2007
  7. pmc Chemotherapy is associated with improved survival in adult patients with primary extremity synovial sarcoma
    Fritz C Eilber
    Division of Surgical Oncology, University of California Los Angeles, Los Angeles, CA, USA
    Ann Surg 246:105-13. 2007
    ..To determine if ifosfamide-based chemotherapy (IF) offers a survival benefit to adult patients with primary extremity synovial sarcoma...
  8. pmc FDG-PET/CT imaging predicts histopathologic treatment responses after the initial cycle of neoadjuvant chemotherapy in high-grade soft-tissue sarcomas
    Matthias R Benz
    Ahmanson Biological Imaging Division, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, California 90095 1782, USA
    Clin Cancer Res 15:2856-63. 2009
    ....
  9. pmc The Friedman-Eilber resection arthroplasty of the pelvis
    Adam J Schwartz
    Department of Orthopaedic Surgery, University of California, Los Angeles Medical Center, Santa Monica, 1250 16th Street, 7th Floor, Los Angeles, CA, 90404, USA
    Clin Orthop Relat Res 467:2825-30. 2009
    ..0; range 16-24). All eight patients ultimately returned to gainful employment. These observations demonstrate independent painless ambulation and acceptable function is possible following resection arthroplasty of the hemipelvis...
  10. ncbi request reprint Evaluation of neoadjuvant therapy and histopathologic response in primary, high-grade retroperitoneal sarcomas using the sarcoma nomogram
    Timothy R Donahue
    Department of Surgery, Division of Surgical Oncology, University of California at Los Angeles, Los Angeles, California 90095 1782, USA
    Cancer 116:3883-91. 2010
    ..Patients with primary high-grade retroperitoneal soft tissue sarcomas have a 5-year disease-specific survival (DSS) of <40%. The impact of neoadjuvant therapy on histopathologic response and DSS are unknown...
  11. ncbi request reprint The multidisciplinary management of osteosarcoma
    Noah Federman
    Division of Pediatric Hematology Oncology, Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095, USA
    Curr Treat Options Oncol 10:82-93. 2009
    ..The treatment of metastatic, recurrent and/or refractory disease is more controversial. Despite advances in systemic treatment, surgical technique, and supportive care, the overall outcome is still poor...
  12. ncbi request reprint Utilization of positron emission tomography in the management of patients with sarcoma
    Matthias R Benz
    Departments of Molecular and Medical Pharmacology, University of California Los Angeles, Los Angeles, California 90095, USA
    Curr Opin Oncol 21:345-51. 2009
    ..In this review, the recent literature covering all aspects of PET imaging in the management of patients with soft tissue and bone sarcomas will be discussed...
  13. pmc Treatment monitoring by 18F-FDG PET/CT in patients with sarcomas: interobserver variability of quantitative parameters in treatment-induced changes in histopathologically responding and nonresponding tumors
    Matthias R Benz
    Ahmanson Biological Imaging Division, Department of Molecular and Medical Pharmacology, University of California at Los Angeles, Los Angeles, California, USA
    J Nucl Med 49:1038-46. 2008
    ..Knowledge of the interobserver variability of quantitative parameters is important in sarcomas as these tumors are frequently large and demonstrate heterogeneous (18)F-FDG uptake...
  14. pmc Combined assessment of metabolic and volumetric changes for assessment of tumor response in patients with soft-tissue sarcomas
    Matthias R Benz
    Department of Molecular and Medical Pharmacology, University of California, Los Angeles, California, USA
    J Nucl Med 49:1579-84. 2008
    ..The aim of this study was to determine whether combined assessment of tumor volume and metabolic activity improves the accuracy of (18)F-FDG PET for predicting histopathologic tumor response in patients with soft-tissue sarcomas...